BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price objective hoisted by analysts at HC W...
HC Wainwright increased their target price on shares of BridgeBio Pharma from $53.00 to $56.00 and g...
BridgeBio Pharma, Inc. (BBIO), a prominent player in the healthcare sector, specifically in biotechn...
BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) was upgraded by analysts at Wall Street Zen from a ...
BridgeBio Pharma (NASDAQ:BBIO) Sets New 1-Year High - Here's What Happened...